Profile
Ng Carey is listed as a director of Immix Biopharma, Inc. in SEC filings with the most recent date provided as May 29, 2026. The available SEC context specifies the director role and the company (Immix Biopharma) but does not disclose additional background such as education, career history, prior board seats, or committee roles. As such, the bio is limited to his position and affiliation as of the filing date.
| Role | Director |
|---|
| Notability | 42/100 |
|---|
Board memberships
Awards & honors
- Listed as a director of Immix Biopharma, Inc. in SEC filings (as of 2026-05-29)
Frequently Asked Questions
Who is Ng Carey?
Ng Carey is listed as a director of Immix Biopharma, Inc. in SEC filings with the most recent date provided as May 29, 2026. The available SEC context specifies the director role and the company (Immix Biopharma) but does not disclose additional background such as education, career history, prior board seats, or committee roles. As such, the bio is limited to his position and a…
How many SEC Form 4 filings has Ng Carey submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Ng Carey's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.